WHO commences Vaccines trials in Nigeria

World Health Organisation WHO has announces commencement of Coronavirus otherwise known as COVID-19 Vaccine trials in Nigeria.

WHO Nigeria and member of the Presidential Task Force (PTF) on COVID-19, Dr. Fiona Braka, has confirm this on Friday in Abuja, at the 24th joint national briefing of the committee.

She also said that 89 vaccines are being developed globally, including seven in clinical evaluation and several therapeutics in clinical trials to tackle the COVID-19 pandemic. She said,

“Nigeria has also expressed interest to be part of this solidarity trial and efforts are underway to start the process in Nigeria too.”

Vaccine Trials

According to her, on the subject of vaccines and clinical trials for Covid-19, research and development is an important aspect of the response and researchers around the world are working hard on accelerating the development of vaccines and therapeutics for Covid-19.

She said the WHO has launched various working groups to accelerate various aspects of vaccine.

Together with global health actors and partners, over the past week, WHO launched the Access to Covid-19 Tools ACT Accelerator, a global collaboration to accelerate development for equitable access to new Covid-19 diagnostics, therapeutics and vaccines.

“We have a total of 89 vaccines that are in development globally, including seven in clinical evaluation and several therapeutics are in clinical trials.

“WHO is committed to ensuring that as medicines and vaccines are developed, they are shared equitably with all countries and people.’

Be the first to comment